Recent Development of Anticancer Therapeutics Targeting Akt

Publisher： Bentham Science Publishers

E-ISSN： 2212-3970|6|1|146-159

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.6, Iss.1, 2011-01, pp. : 146-159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Development in Targeting PI3K-Akt-mTOR Signaling for Anticancer Therapeutic Strategies

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 10, 2013-12 ,pp. : 1552-1564

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances and Approaches in Targeting Apoptosis Signaling Pathways for Anti-Cancer Therapeutics

By  

Current Cancer Therapy Reviews, Vol. 6, Iss. 4, 2010-11 ,pp. : 262-282

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments in Anti-Cancer Agents Targeting PI3K, Akt and mTORC1/2

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 6, Iss. 2, 2011-05 ,pp. : 210-236

Bentham Science Publishers

Access to resources Recommend Favorite

The Applications of Targeting Anti-Cancer Agents in Cancer Therapeutics

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 7, 2015-01 ,pp. : 869-880

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in the Development of Anticancer Agents

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 2, Iss. 3, 2002-05 ,pp. : 419-439

Bentham Science Publishers

Access to resources Recommend Favorite